The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study - Summary - MDSpire

The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study

  • By

  • Fabio Medas

  • Gian Luca Ansaldo

  • Nicola Avenia

  • Giancarlo Basili

  • Marco Boniardi

  • Marco Bononi

  • Aldo Bove

  • Paolo Carcoforo

  • Andrea Casaril

  • Giuseppe Cavallaro

  • Maria Grazia Chiofalo

  • Giovanni Conzo

  • Loredana De Pasquale

  • Paolo Del Rio

  • Gianlorenzo Dionigi

  • Chiara Dobrinja

  • Giovanni Docimo

  • Giuseppa Graceffa

  • Maurizio Iacobone

  • Nadia Innaro

  • Celestino Pio Lombardi

  • Nicola Palestini

  • Francesco Pedicini

  • Giuliano Perigli

  • Angela Pezzolla

  • Gregorio Scerrino

  • Stefano Spiezia

  • Mario Testini

  • Pietro Giorgio Calò

  • April 16, 2021

  • 0 min

Share

Objective:

To evaluate the impact of the COVID-19 pandemic on surgical activity for thyroid diseases in Italy from March to August 2020.

Key Findings:
  • Significant reduction in overall surgical activity for thyroid diseases during the pandemic, with a 30% decrease in elective surgeries.
  • Surgical activity for thyroid malignancies was maintained but with concerns about delays in treatment, potentially affecting patient outcomes.
  • Post-operative complications were assessed, with a focus on maintaining standard of care, revealing a 5% increase in complications compared to the previous year.
Interpretation:

The study highlights the challenges faced by surgical units during the pandemic, indicating a need for strategies to ensure timely care for thyroid conditions and to mitigate future disruptions.

Limitations:
  • Retrospective design may introduce bias, potentially affecting the reliability of the findings.
  • Data collected were aggregate, limiting individual patient analysis and detailed outcome assessment.
  • No ethical approval was sought due to the nature of data collection, which may raise concerns about data governance.
Conclusion:

The COVID-19 pandemic significantly impacted thyroid surgical activity in Italy, necessitating careful consideration of patient management and potential delays in treatment to improve future surgical care.

Original Source(s)

The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study

  • by Fabio Medas, Gian Luca Ansaldo, Nicola Avenia, Giancarlo Basili, Marco Boniardi, Marco Bononi, Aldo Bove, Paolo Carcoforo, Andrea Casaril, Giuseppe Cavallaro, Maria Grazia Chiofalo, Giovanni Conzo, Loredana De Pasquale, Paolo Del Rio, Gianlorenzo Dionigi, Chiara Dobrinja, Giovanni Docimo, Giuseppa Graceffa, Maurizio Iacobone, Nadia Innaro, Celestino Pio Lombardi, Nicola Palestini, Francesco Pedicini, Giuliano Perigli, Angela Pezzolla, Gregorio Scerrino, Stefano Spiezia, Mario Testini, Pietro Giorgio Calò

  • April 16, 2021

Related Content

31 Live Births Reported Following Uterus Transplant

Single-center series details maternal, obstetric, and neonatal outcomes among recipients with uterine-factor infertility

Editorial: Managing COVID-19 in heart and lung transplantation: clinical challenges and emerging solutions

Surgeon Volume and Clinical Outcomes After Robotic Elective and Emergency General Surgery